Baby Immunisation Schedule India 2026: IAP Guidelines, Government vs Private Vaccines & Complete Cost Breakdown

This guide walks you through India's baby immunisation schedule 2026 with clarity on government vs private options, vaccine brands actually used in Indian clinics, side effects you should watch for, and honest cost breakdowns. I've cross-referenced the latest IAP (Indian Academy of Pediatrics): India's premier paediatric body that sets vaccine recommendations for all states-with what's actually available and affordable across tier-1, tier-2, and tier-3 cities.

Government vs Private Vaccines: What's Included & What Costs

Let me be direct: India's government immunisation programme, run by the Ministry of Health, offers essential vaccines completely free through primary health centers (PHCs) and ASHA workers. Your baby gets protection without paying a single rupee. But there's a gap-several vaccines recommended by IAP and WHO are not part of the free schedule. That's where private clinics step in, and that's where costs multiply.

Government Free Immunisation Schedule (2026):

• Birth: BCG (tuberculosis), Hepatitis B birth dose
• 6, 10, 14 weeks: DPT (diphtheria, pertussis, tetanus), Polio (IPV), Hepatitis B
• 9 months: Measles (MR vaccine)
• 12-18 months: Booster doses of DPT, Polio, and second dose of Measles
• 4-6 years: DPT and Polio boosters

Total Cost: ₹0 (completely free at government health facilities)

Private Hospital Vaccine Packages (2026 pricing): Most private clinics in Mumbai, Delhi, Bengaluru, Pune, Chennai, and Lucknow offer bundled packages that add rotavirus, PCV (pneumococcal conjugate), varicella (chickenpox), and HPV (human papillomavirus) vaccines to the government schedule.

• Basic Private Package: Government vaccines + Rotavirus (3 doses) + PCV (3 doses) = ₹15,000-₹22,000
• Premium Package: Above + Varicella + Typhoid + Japanese Encephalitis (JE, state-dependent) = ₹28,000-₹40,000
• Ultra-Premium: All of above + HPV for girls (2 doses, ages 9-14) = ₹40,000-₹50,000

Key Vaccines Added in Private Schedules: Do You Need Them?

Rotavirus Vaccine: Prevents severe diarrhoea. Three doses at 6, 10, and 14 weeks. Cost: ₹3,000-₹5,000 total. IAP recommends it for all infants; WHO lists it as crucial in countries with high diarrhoea mortality. Government doesn't provide it because diarrhoea management (ORS rehydration) is available free, but vaccination prevents hospitalisation.

Pneumococcal Conjugate Vaccine (PCV): Protects against 13 strains of pneumococcus bacteria, which cause pneumonia, meningitis, and ear infections. Three doses at 6, 10, and 14 weeks, plus a booster at 12-15 months. Cost: ₹4,000-₹6,500 total. IAP strongly recommends PCV13 for all infants. It's not free because pneumococcal disease, while serious, is less common than tuberculosis or polio in India-but it's still a leading cause of preventable paediatric meningitis.

Varicella (Chickenpox): Two doses at 12-15 months and 18-24 months. Cost: ₹2,500-₹4,000. Chickenpox is common in India, especially in tier-1 cities. Most paediatricians recommend it to prevent school absences and complications like bacterial skin infections.

HPV Vaccine (Girls only): Two doses between ages 9-14 years. Cost: ₹6,000-₹10,000 total. Prevents cervical cancer in 99% of cases. WHO recommends HPV for all girls globally; IAP includes it in 2026 guidelines. Not free because cervical cancer prevention is a long-term public health strategy, not an immediate infectious disease concern like polio.

Vaccine Brands Used in India: What Your Baby Gets

Government clinics use vaccines procured centrally by the Ministry of Health. Common brands include Serum Institute of India (SII) products for DPT, polio, and measles, and Bharat Biotech's rotavirus and varicella vaccines (where available). All are BIS-certified and meet WHO standards.

Private clinics source from multiple manufacturers:

All these brands are approved by the Central Drugs Standard Control Organization (CDSCO) and follow the same potency and safety standards as WHO-prequalified vaccines. The difference is price and convenience-government clinics use lower-cost bulk procured vaccines; private clinics mix domestic (SII, Bharat Biotech) and imported brands (Pfizer, GSK).

Common Vaccine Side Effects & When to Call Your Paediatrician

Normal reactions: Low fever (100-101°F) within 24 hours, mild redness or swelling at injection site, fussiness for a few hours. These pass on their own.

When to seek medical help: Fever above 102°F, swelling that doesn't reduce within 48 hours, rash appearing 1-2 weeks after MMR or varicella (varicella-like rash is expected with varicella vaccine), or breathing difficulty. Serious side effects are rare-AEFI (Adverse Events Following Immunisation) severe enough to hospitalize occur in fewer than 1 in 100,000 doses in India, according to ICMR surveillance data.

Mandatory vs Optional: What You Actually Need to Know

Government vaccines (DPT, polio, measles, BCG, hepatitis B) are mandatory for school admission and legally required under the Immunisation Act in some states. Rotavirus, PCV, varicella, and HPV are medically recommended by IAP but not legally mandatory-the choice is yours.

State-wise availability note: Some states like Gujarat and Tamil Nadu have added PCV to their government schedule in 2025-2026. Delhi and Maharashtra offer rotavirus through select government facilities. Check your state's health department website for updates specific to Mumbai, Delhi, Bengaluru, Chennai, or Lucknow.

Gaps between doses matter: If your baby misses a scheduled dose, don't restart the series. Resume from where you left off, following the standard 4-week gap between doses. A delay of a few weeks won't affect immunity; a delay of several months is fine too-catch-up vaccination is always possible.

The bottom line: Your baby's core protection comes from government vaccines-free, proven, and effective. Private additions (especially rotavirus and PCV) are valuable if you can afford them, but not essential if finances are tight. Talk to your paediatrician about your specific situation, access to follow-up care, and local disease patterns.